Please provide your email address to receive an email when new articles are posted on . Use of the DETECT algorithm was a better screening tool for systemic sclerosis-associated peripheral arterial ...
The CHEST 2012 meeting features a number of newly published studies for a wide variety of disease states ranging from tuberculosis to lung disease. The following are highlights of hypertension ...
At Janssen, our mission is to put the needs and well-being of the people we serve as a top priority. As part of the larger healthcare ecosystem, we also recognize our responsibility to listen to and ...
Screening for a sometimes fatal condition among patients with a rare autoimmune disease could soon - thanks to a computer algorithm - become even more accurate. Researchers at Michigan Medicine found ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leading AI-driven health technology company and portfolio company of nference, announced a new study that revealed promising results in support of further ...
Though it affects only somewhere between 0.1% and 1% of the world’s population, pulmonary hypertension can carry an outsized mortality risk. That’s due to its largely nonspecific symptoms—including ...
Having a diagnostic model that leverages artificial intelligence could fill a gap in the pulmonary hypertension (PH) diagnostic pathway, as there are currently just 2 validated screening algorithms ...
A Mayo Clinic and Janssen-backed venture has received FDA breakthrough designation for an algorithm designed to enable early detection of pulmonary hypertension. Anumana Inc. received the breakthrough ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback